DEXCOM INC — Director's Dealing 2015

Mar 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-03-11

Reporting Person: Pacelli Steven Robert (EVP, Strategy & Corp. Dev.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-11	Common Stock	D	6320.0	$58.7402	Disposed	267546	Direct
2015-03-11	Common Stock	D	12529.0	$58.7402	Disposed	255017	Direct
2015-03-12	Common Stock	D	6371.0	$58.5762	Disposed	248646	Direct

Footnotes

F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.

F2: Included in this number are 116,207 unvested restricted stock units, 45,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 47,333 of which were granted on March 8, 2014 and shall vest through March 8, 2017, and 23,874 of which were granted on March 11, 2013 and shall vest through March 11, 2016.